毫针针刺治疗过敏性鼻炎的系统评价与Meta分析
结果显示毫针针刺可显著改善症状评分、生活质量及减少药物使用,且安全性良好,但部分证据质量较低。
要点
- 毫针针刺较假针刺显著降低症状评分(SMD=-0.29)并改善生活质量(SMD=-0.23)。
- 毫针针刺较不治疗大幅降低症状评分(SMD=-0.8)及改善生活质量(SMD=-0.82)。
- 毫针针刺不增加不良事件,且患者满意度更高,可能具有成本效益。
核心结论
- 毫针针刺是治疗过敏性鼻炎有效且安全的干预措施,有助于缓解症状、改善生活质量、减少药物使用并提高患者满意度。
主要发现
- 与假针刺相比,毫针针刺显著降低症状评分(SMD:-0.29 [-0.43, -0.15])、改善生活质量(SMD:-0.23 [-0.37, -0.08])和减少药物评分(SMD:-0.3 [-0.49, -0.11])。
- 与不治疗相比,毫针针刺显著降低症状评分(SMD:-0.8 [-1.2, -0.39])和改善生活质量(SMD:-0.82 [-1.13, -0.52])。
- 与常规药物相比,毫针针刺显著降低症状评分(SMD:-0.48 [-0.85, -0.1])且不良事件率更低,但证据质量极低。
- 毫针针刺较假针刺和不治疗未增加不良事件率,并提高患者满意度,可能具有成本效益。
关键数值与推荐
- 主要结局为症状评分(总鼻症状评分或视觉模拟量表),次要结局包括过敏性鼻炎控制问卷、生活质量评分、药物评分、心理健康评分、总IgE、不良事件率、临床经济指标和患者满意度。
- 连续数据采用标准化均数差(SMD)或均数差(MD)及95%置信区间,二分类数据采用风险比及95%置信区间。
临床怎么用
- 毫针针刺可用于过敏性鼻炎患者的症状控制和生活质量改善,尤其适用于希望减少常规药物使用或对药物耐受不佳者。
- 临床决策时应考虑毫针针刺安全性良好且可能节省费用,但对其优于常规药物的证据需谨慎解读。
局限性
- 部分比较(如与常规药物相比)的证据质量极低,需进一步研究验证。
- 成本效益及最佳治疗策略尚需更多研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Filiform needle acupuncture (FNA), the most classical and widely applied acupuncture method based on traditional Chinese medicine theory, has shown a promising effect in the treatment of allergic rhinitis (AR). OBJECTIVE: To evaluate the efficacy, safety, cost-effectiveness, and patient preference of FNA in the treatment of AR by comparing FNA with sham acupuncture, no treatment, and conventional medication. SEARCH STRATEGY: Eight electronic databases were systematically searched from inception to October 14, 2021. Additional studies were acquired from clinical trial registration platforms and reference lists. INCLUSION CRITERIA: Randomized controlled trials were included if they compared FNA with either sham acupuncture, no treatment or conventional medication for AR. DATA EXTRACTION AND ANALYSIS: Two researchers extracted data independently of each other using a predesigned data acquisition form, and results were cross-checked after completion. The primary outcome was symptom score (Total Nasal Symptom Score or Visual Analogue Scale), and the secondary outcomes were the AR control questionnaire, quality of life (QoL) score (Different versions of Rhinoconjunctivitis Quality of Life Questionnaire), medication score (use of rescue medication), mental health score, total IgE, adverse event rate, clinical economic indicators, and patient satisfaction score. Standardized mean difference (SMD) or mean difference (MD) with 95% confidence interval was used to calculate the effect size for continuous data, while risk ratio with 95% CI was used for dichotomous data. RESULTS: Thirty studies were included in this review. Compared with sham acupuncture, FNA significantly reduced the symptom score (SMD: -0.29 [-0.43, -0.15]), AR's impact on QoL (SMD: -0.23 [-0.37, -0.08]) and medication score (SMD: -0.3 [-0.49, -0.11]). Compared with no treatment, FNA dramatically reduced the symptom score (SMD: -0.8 [-1.2, -0.39]) and AR's impact on QoL (SMD: -0.82 [-1.13, -0.52]). There were no increased rates of adverse events with FNA compared to sham acupuncture and no treatment. FNA increased patient satisfaction and may be cost-effective. Most pieces of evidence from the above two comparisons were of high confidence. Moreover, FNA significantly outperformed conventional medication in reducing the symptom score (SMD: -0.48 [-0.85, -0.1]) and displayed a lower rate of adverse events, but the quality of evidence was very low. CONCLUSION: FNA is an effective and safe intervention for AR and can help with symptom relief, QoL improvement, reducing medication usage, and increasing patient satisfaction. Further studies are needed to verify its cost-effectiveness and superiority over conventional medication and the best therapeutic strategies.
引用
- Du SH, Guo W, Yang C, et al. Filiform needle acupuncture for allergic rhinitis: A systematic review and meta-analysis. J Integr Med. 2022. PMID: 36068161. doi:10.1016/j.joim.2022.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。